About this file

This document is an Award Synopsis for a federal contract opportunity titled "Rational Systemic Characterization and Selection of Adjuvants for HIV Vaccine Candidates (R-CASA)". The contract was awarded on August 1, 2024 to Scripps Research Institute for a total estimated cost of $9,587,256, with a period of performance from August 1, 2024 through July 31, 2029. The contract was awarded under Solicitation No. BAA-DAIDS-75N93022R00017 with a NAICS code of 541712. The primary point of contact is Ashley Kinderdine, Contracting Officer, at ashley.kinderdine@nih.gov. The award was issued by the Department of Health and Human Services, National Institutes of Health, National Institute of Allergy and Infectious Diseases.

View the file

On GovTribe

Work with this file

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

AWARD SYNOPSIS

Type: Award

Date of Award: August 1, 2024

Period of Performance (including all options): August 1, 2024 through July 31, 2029

Title: “Rational Systemic Characterization and Selection of Adjuvants for HIV Vaccine

Candidates (R-CASA)”

(RFP) No.: BAA-DAIDS-75N93022R00017

NAICS: 541712, Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)

Contract Number: 75N93024C00053 (Scripps Research Institute)

Total Estimated Cost (Including all Options): $9,587,256

Place of Performance/Awardee:

Scripps Research Institute 10550 N Torrey Pines Rd La Jolla, CA 92037

Unique Entity ID: PHZJFZ32NKH4

Primary Point of Contact at NIAID: Ashley Kinderdine Contracting Officer ashley.kinderdine@nih.gov mailto:ashley.kinderdine@nih.gov

File details come from the government source that posted it. Updated .